dmea-pnu-159682

DMEA-PNU-159682 (molecule D12) is an ADC cytotoxin molecule that includes neomycin (MMDX) metabolites from liver microsomes and the effective ADC cytotoxin PNU-159682.

DMEA-PNU-159682 (molecule D12) dichloroacetate, 作为一种ADC细胞毒素分子，由肝微粒体的新霉素代谢产物 (MMDX) 与高效的ADC细胞毒素PNU-159682组成。

DBCO-PEG4-VC-PAB-DMEA-PNU-159682, a drug-linker conjugate for antibody-drug conjugates (ADC), comprises the ADC linker DBCO-PEG4-VC-PAB and the potent ADC cytotoxin DMEA-PNU-159682. The cytotoxin includes metabolites of nemorubicin (MMDX) from liver microsomes and the ADC cytotoxin PNU-159682[1].

Mal-PEG4-VC-PAB-DMEA-PNU-159682 is a drug-linker conjugate designed for antibody-drug conjugate (ADC) therapy. It combines the ADC linker, Mal-PEG4-VC-PAB, with the potent ADC cytotoxin, DMEA-PNU-159682. The cytotoxin, DMEA-PNU-159682, is derived from metabolites of nemorubicin (MMDX) found in liver microsomes, as well as the ADC cytotoxin PNU-159682[1].

Mal-Phe-C4-VC-PAB-DMEA-PNU-159682 is a drug-linker conjugate utilized in antibody-drug conjugate (ADC) therapy. It comprises the ADC linker Mal-Phe-C4-VC-PAB and the potent ADC cytotoxin DMEA-PNU-159682. DMEA-PNU-159682 encompasses metabolites of nemorubicin (MMDX) derived from liver microsomes, as well as the ADC cytotoxin PNU-159682[1].

Mal-VC-PAB-DMEA-PNU-159682 是一种结合于 ADC 的药物-连接体结合物，通过溶酶体可裂解的二肽 Mc-VC-PAB 将抗拓扑异构酶 II 抑制剂 PNU-159682 进行连接，展现出强效的抗肿瘤活性。该化合物可用于合成 Anti-CD22-NMS249。

vc-PAB-DMEA-PNU159682 (compound I.47) 在制备基于磺马莱亚胺基连接子的抗体偶联活性分子 (ADC) 时被广泛使用。此化合物表现出优异的血清稳定性。